Five-year follow-up sustained remission with rituximab in a patient with focal segmental glomerulosclerosis: A case report

doi:10.5527/wjn.v15.i1.116620

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-1)

Sum=36

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=8

Mar 25, 2026 (publication date) through Mar 14, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Nephrol. Mar 25, 2026; 15(1): 116620
Published online Mar 25, 2026. doi: 10.5527/wjn.v15.i1.116620

Open in New Tab Full Size Figure Download Figure

Figure 1 Medical history timeline of patient remissions and relapses.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kidney histology by light microscopy of patient with primary focal segmental glomerulosclerosis. A: Grocott-Methenamine-Silver staining 400×. Glomerulus with probable tubular pole adhesion and area of podocyte turgescence, suggesting a tip lesion variant; B: Hematoxylin-eosin staining 400×. Glomerulus with flocculocapsular adhesion at the hilar pole and area of podocyte turgor.

Citation: Moura AF, Rocha PN, Moura-Landim D, Moura Jr JA, Moura-Neto JA. Five-year follow-up sustained remission with rituximab in a patient with focal segmental glomerulosclerosis: A case report. World J Nephrol 2026; 15(1): 116620
URL: https://www.wjgnet.com/2220-6124/full/v15/i1/116620.htm
DOI: https://dx.doi.org/10.5527/wjn.v15.i1.116620